Long-acting lacidipine versus short-acting nifedipine in the treatment of asymptomatic acute blood pressure increase

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 3, 1999, Pages 479-484

  Sanchez M ^b   Sobrino, J ^a   Ribera, L ^a   Adrian M J ^a   Torres, M ^a   Coca, A ^b  

^a Hospital Esperit Sant   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Hypertensive crisis; Hypertensive urgencies; Lacidipine; Nifedipine

Indexed keywords

CALCIUM ANTAGONIST; LACIDIPINE; LONG ACTING DRUG; NIFEDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; DIASTOLE; DIHYDROPYRIDINES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; REFERENCE VALUES; SINGLE-BLIND METHOD; SYSTOLE; TREATMENT OUTCOME;

EID: 0032994231     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199903000-00019     Document Type: Article

References (20)

1. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Publication 98-4080. Bethesda: National Institutes of Health, 1997.
2. Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med 1990;323:1177-83.
3. Vidt DG, Gifford RW. A compendium for the treatment of hypertensive emergencies. Cleve Clin Q 1984;51:421-30.
4. Vidt DG. Current concepts in treatment of hypertensive emergencies. Am Heart J 1986;111:220-5.
5. Magometschnigg D. Zur Therapie bei hypertenen krisen. Nifedip-ine per os. Dtsch Med Wochenschr 1982;107:1423-8.
6. Schillinger D. Nifedipine in hypertensive emergencies: a prospective study. J Emerg Med 1987;5:463-73.
7. Micheli D, Ratti E, Toson G, Gaviraghi G. Pharmacology of lacidipine: a vascular-selective calcium antagonist. J Cardiovasc Pharmacol 1991;17(suppl 4):Sl-8.
8. Leonetti G. Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study: the Northern Italian Study Group of Lacidipine in Hypertension. J Cardiovasc Pharmacol 1991;17(suppl 4):S31-4.
9. Zampaglione B, Pascale C, Marchisio M, Santoro A. The use of lacidipine in the management of hypertensive crises: a comparative study with nifedipine. J Cardiovasc Pharmacol 1994;23(suppl 5):S116-8.
10. Cohan J. Nifedipine in the management of hypertensive emergencies: report of two cases and review of the literature. Am J Emerg Med 1985;3:524-53.
11. Hirschl MM. Guidelines for the drug treatment of hypertensive crises. Drugs 1995:50:991-1000.
12. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks, Br J Obstet Gynaecol 1993;100: 959-61.
13. O'Mailia JJ, Sander GE, Giles TD. Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med 1987;107:185-6.
14. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995:274:620-5.
15. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. JAMA 1997;277:739-45.
16. Pahor M, Guralnik JM, Corti MC, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43:1191-7.
17. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
18. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338:645-52.
19. Epstein M. Calcium antagonists should continue to be used as first-line treatment of hypertension. Arch Intern Med 1995;155: 2150-6.
20. Lindqvist M, Kahan T, Melcher A, Hjemdahl P. Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension. Hypertension 1994;24:287-96.